Why isotretinoin still matters
Isotretinoin (commonly known by the brand name Accutane, discontinued in the US but available globally as Roaccutane, Claravis, Absorica, and various generics) is the most effective oral medication available for severe and moderate acne. It is the only treatment that fundamentally changes sebum production, shrinks sebaceous glands, and produces sustained remission in 70–80% of completed-course patients. For severe nodulocystic acne, scarring acne, or acne resistant to topical treatments and antibiotics, isotretinoin remains the standard of care globally.
Korea has prescribed isotretinoin since the 1980s and has built one of the most established outpatient dermatology protocols globally. The cost difference between Korea and Western markets is dramatic (10–20x less for the same medication), making Korea a relevant destination for international patients seeking treatment.
How isotretinoin works
- Suppresses sebaceous gland activity (reduces oil production by 70–90%)
- Shrinks gland size, with effect persisting after treatment ends
- Reduces follicular keratinization (the clogging mechanism)
- Decreases C. acnes bacterial counts
- Modulates inflammation in skin tissue
- Effects accumulate over months — not a quick-fix medication
Korean prescribing protocol
Initial consultation
- Dermatologist assessment of acne severity and type
- Review of prior treatments tried
- Discussion of treatment expectations and timeline
- Pregnancy prevention counseling (mandatory for female patients of reproductive age)
- Baseline blood tests: liver function, lipid panel, complete blood count, pregnancy test if applicable
Dosing
Korean dermatology uses two common dosing approaches:
- Standard dose: 0.5–1.0 mg/kg/day for 4–6 months, targeting cumulative dose of 120–150 mg/kg
- Low-dose protocol: 20 mg/day (regardless of weight) for 6–12 months for milder cases or sensitive patients
Choice depends on acne severity, patient size, and tolerance considerations. Korean protocols increasingly favor low-dose extended treatment for moderate acne due to better tolerability and similar long-term remission rates.
Monitoring
- Monthly clinic visits during treatment
- Monthly blood tests (liver function, cholesterol/triglycerides)
- Female patients: monthly pregnancy tests
- Dosage adjustments based on response and side effect profile
- Skin assessment for treatment progress
Costs in Korea (2026)
- Initial dermatology consultation: ₩20,000–60,000 ($15–45)
- Monthly prescription (typical 30 mg/day): ₩30,000–70,000 ($23–53)
- Monthly blood tests: ₩30,000–80,000 ($23–60)
- Total 4–6 month course: ₩300,000–800,000 ($230–600)
- Total 12-month low-dose course: ₩600,000–1,500,000 ($450–1,130)
Comparable US course: $1,500–4,000 with insurance, $4,000–8,000 without. The Korea cost advantage is significant.
Common side effects
Universal effects (essentially all patients)
- Severe dryness — lips, skin, nasal passages, eyes
- Need for constant moisturizer use
- Increased sun sensitivity
- Some hair shedding (usually temporary)
Common effects (30–50% of patients)
- Joint and muscle aches
- Mood changes (mild)
- Headaches
- Fatigue
- Elevated cholesterol/triglycerides during treatment
Less common but serious
- Significant depression or suicidal ideation (controversial association but monitored)
- Liver enzyme elevation requiring dose adjustment
- Inflammatory bowel disease (rare association)
- Vision changes (especially night vision)
- Pseudotumor cerebri (very rare)
Pregnancy-related (absolute contraindication)
Isotretinoin is severely teratogenic. Pregnancy during treatment essentially guarantees severe birth defects or pregnancy loss. Korean protocol requires:
- Two negative pregnancy tests before starting
- Two forms of contraception during treatment
- Continuation of contraception 1 month after treatment ends
- Monthly pregnancy testing
Korean K-beauty support during isotretinoin
The dryness from isotretinoin is severe enough that supportive skincare matters significantly. Korean dermatology routinely prescribes alongside medication:
- Aestura Atobarrier 365 Cream: ceramide-heavy moisturizer for severe barrier compromise
- Vaseline Lip Therapy or similar: constant lip protection
- Aquaphor / Bepanthen for nostril application
- Artificial tears for dry eyes
- Beauty of Joseon Relief Sun or mineral sunscreen daily
- Avoidance of any active actives: no retinol, AHA, BHA, vitamin C, fragrances
For international patients
- Many Gangnam dermatology clinics offer English-speaking consultation
- Some international patients complete 1–2 months in Korea then continue prescription via teleconsultation
- Verify your home country\'s import regulations for isotretinoin
- Some countries require local prescription transfer for continuation
- Travel insurance often does not cover acne treatment abroad
Who is a candidate?
- Moderate to severe acne
- Acne resistant to topical treatments and oral antibiotics
- Acne causing scarring
- Acne significantly affecting psychosocial wellbeing
- Patient capable of completing treatment with monitoring
- Female patients on reliable contraception
Wrong candidates
- Mild acne (topical treatments sufficient)
- Active or planned pregnancy
- Significant liver disease
- Active depression or suicide risk (relative contraindication)
- Patients unable to comply with monthly monitoring
- Female patients unwilling to use contraception
- Allergies to vitamin A derivatives or product excipients
What happens after treatment
- 70–80% achieve sustained remission (no acne return)
- 20–30% have recurrence within 2 years, may need second course
- Sebum production gradually returns but typically lower than pre-treatment baseline
- Acne scars present at start do not resolve from isotretinoin — separate scar treatment needed
- Korean dermatology often combines post-isotretinoin scar treatment (laser, subcision, RF microneedling)
Honest framing
Isotretinoin works. The clinical evidence is decades deep. Korean dermatology runs this medication well, with strict monitoring and affordable pricing relative to Western markets. For international patients with severe acne who can\'t afford or access treatment at home, Korea is a legitimate option. The treatment is real medical therapy with real risks — choose properly licensed dermatology clinics (not cosmetic-only centers), verify the doctor is board-certified in dermatology specifically, and commit to the full monitoring protocol. Skipping the blood tests or pregnancy testing to save money is dangerous. The Korean pricing advantage exists because of efficient delivery, not because of corners cut on safety.